Sean Colm Turner

City:

Mannheim

Country:

Germany

Published Applications:

Last publication date:

2014-05-29

Top Assignees for applications by Sean Colm Turner

The entities that hold a legal rights for patent applications filed by inventor Turner Sean Colm:

Abbott GmbH & Co. KG 7 Wiesbaden, Germany
Abbott GmbH & Co. KG 5 Wiesbaden, Germany
AbbVie Deutschland GmbH & Co. KG 3 Wiesbaden, Germany
Abbott Laboratories 2 Abbott Park, IL United States
ABBVIE INC. 2 North Chicago, IL United States

Recent patent applications by Turner Sean Colm

Sean Colm Turner from Mannheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-05-29

US20140148458A1

Chemistry; metallurgy

Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors

#2 | 2011-12-01

US20110294817A1

Chemistry; metallurgy

N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor

#3 | 2011-05-05

US20110105528A1

Chemistry; metallurgy

1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)

#4 | 2011-04-14

US20110086863A1

Chemistry; metallurgy

BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

#5 | 2010-12-23

US20100324042A1

Chemistry; metallurgy

Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors

#6 | 2010-02-25

US20100048582A1

Chemistry; metallurgy

Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

#7 | 2009-12-10

US20090306175A1

Chemistry; metallurgy

Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

#8 | 2009-06-04

US20090143383A1

Chemistry; metallurgy

Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

#9 | 2009-05-21

US20090131452A1

Chemistry; metallurgy

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

InventorID:

779538 ⎘